<DOC>
	<DOCNO>NCT02162407</DOCNO>
	<brief_summary>This study conduct Europe . The aim study estimate relationship pharmacodynamic interstitial pharmacokinetic steady state follow intravenous ( i.v . ) administration insulin detemir human soluble insulin .</brief_summary>
	<brief_title>A Trial Investigating Relationship Between Pharmacodynamic Interstitial Concentration Insulin Detemir Human Insulin</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Healthy male 19 50 year inclusive The subject must give sign informed consent trial related activity . ( Trial relate activity procedure would perform normal management subject ) Body Mass Index ( BMI ) 27 kg/m^2 Fasting blood glucose maximum 6 mmol/l Participation clinical trial involve investigational product within last 3 month</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>